Literature DB >> 8876135

Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.

T R Jones1, E J Wiertz, L Sun, K N Fish, J A Nelson, H L Ploegh.   

Abstract

The human cytomegalovirus (HCMV) early glycoprotein products of the US11 and US2 open reading frames cause increased turnover of major histocompatibility complex (MHC) class I heavy chains. Since US2 is homologous to another HCMV gene (US3), we hypothesized that the US3 gene product also may affect MHC class I expression. In cells constitutively expressing the HCMV US3 gene, MHC class I heavy chains formed a stable complex with beta 2-microglobulin. However, maturation of the N-linked glycan of MHC class I heavy chains was impaired in US3+ cells. The glycoprotein product of US3 (gpUS3) occurs mostly in a high-mannose form and coimmunoprecipitates with beta 2-microglobulin associated class I heavy chains. Mature class I molecules were detected at steady state on the surface of US3+ cells, as in control cells. Substantial perinuclear accumulation of heavy chains was observed in US3+ cells. The data suggest that gpUS3 impairs egress of MHC class I heavy chains from the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876135      PMCID: PMC38057          DOI: 10.1073/pnas.93.21.11327

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Virus proteins that counteract host immune defenses.

Authors:  L R Gooding
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

2.  A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family.

Authors:  T R Jones; V P Muzithras
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 3.  Molecular anatomy of viral persistence.

Authors:  M B Oldstone
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain.

Authors:  A Hill; M Takiguchi; A McMichael
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Association of human class I MHC alleles with the adenovirus E3/19K protein.

Authors:  D C Beier; J H Cox; D R Vining; P Cresswell; V H Engelhard
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

6.  Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression.

Authors:  A E Campbell; J S Slater
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains.

Authors:  M F Beersma; M J Bijlmakers; H L Ploegh
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

8.  Human cytomegalovirus UL36-38 and US3 immediate-early genes: temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection.

Authors:  D J Tenney; A M Colberg-Poley
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes.

Authors:  T W Hermiston; R A Tripp; T Sparer; L R Gooding; W S Wold
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment.

Authors:  M del Val; H Hengel; H Häcker; U Hartlaub; T Ruppert; P Lucin; U H Koszinowski
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  133 in total

1.  Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.

Authors:  S Ishido; C Wang; B S Lee; G B Cohen; J U Jung
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.

Authors:  U Reusch; W Muranyi; P Lucin; H G Burgert; H Hengel; U H Koszinowski
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

3.  Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules.

Authors:  S Lee; J Yoon; B Park; Y Jun; M Jin; H C Sung; I H Kim; S Kang; E J Choi; B Y Ahn; K Ahn
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus.

Authors:  H Hengel; U Reusch; G Geginat; R Holtappels; T Ruppert; E Hellebrand; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 5.  Lessons from viral manipulation of protein disposal pathways.

Authors:  Margo H Furman; Hidde L Ploegh
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

6.  MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.

Authors:  C Benz; H Hengel
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

Review 7.  The MHC class I antigen presentation pathway: strategies for viral immune evasion.

Authors:  Eric W Hewitt
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules.

Authors:  Elisabeth Sievers; Jürgen Neumann; Martin Raftery; Günther SchOnrich; Anna Maria Eis-Hübinger; Norbert Koch
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

9.  Characterization of the human cytomegalovirus UL34 gene.

Authors:  B J Biegalke; E Lester; A Branda; R Rana
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 10.  Virus subversion of protective immunity.

Authors:  Eric W Hewitt; Gillian E Dugan
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.